MA47223A - Conjugués polypeptide-antigène avec des acides aminés non naturels - Google Patents
Conjugués polypeptide-antigène avec des acides aminés non naturelsInfo
- Publication number
- MA47223A MA47223A MA047223A MA47223A MA47223A MA 47223 A MA47223 A MA 47223A MA 047223 A MA047223 A MA 047223A MA 47223 A MA47223 A MA 47223A MA 47223 A MA47223 A MA 47223A
- Authority
- MA
- Morocco
- Prior art keywords
- polypeptide
- amino acids
- natural amino
- antigen conjugates
- conjugates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0208—Specific bacteria not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662441115P | 2016-12-30 | 2016-12-30 | |
US201762530803P | 2017-07-10 | 2017-07-10 | |
US201762568201P | 2017-10-04 | 2017-10-04 | |
US201762591160P | 2017-11-27 | 2017-11-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA47223A true MA47223A (fr) | 2019-11-06 |
Family
ID=62710794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA047223A MA47223A (fr) | 2016-12-30 | 2017-12-29 | Conjugués polypeptide-antigène avec des acides aminés non naturels |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP3562503A2 (fr) |
JP (1) | JP7186166B2 (fr) |
KR (1) | KR20190103256A (fr) |
CN (1) | CN110366428B (fr) |
AU (1) | AU2017388891A1 (fr) |
BR (1) | BR112019013475A2 (fr) |
CA (1) | CA3048981A1 (fr) |
IL (1) | IL267709A (fr) |
MA (1) | MA47223A (fr) |
MX (2) | MX2019007910A (fr) |
PH (1) | PH12019501552A1 (fr) |
WO (1) | WO2018126229A2 (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
CN110337307A (zh) | 2017-02-24 | 2019-10-15 | 默沙东公司 | 增强肺炎链球菌多糖-蛋白缀合物的免疫原性 |
EP3678652A4 (fr) | 2017-09-07 | 2021-05-19 | Merck Sharp & Dohme Corp. | Polysaccharides antipneumococciques et leur utilisation dans des conjugués immunogènes polysaccharide-protéine porteuse |
CN116898959A (zh) | 2017-09-07 | 2023-10-20 | 默沙东有限责任公司 | 肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途 |
WO2020010000A1 (fr) | 2018-07-04 | 2020-01-09 | Sutrovax, Inc. | Procédés améliorés pour la préparation de conjugués immunogènes |
WO2020010016A1 (fr) | 2018-07-04 | 2020-01-09 | Sutrovax, Inc. | Conjugués immunogènes auto-adjuvés |
CA3105361A1 (fr) * | 2018-07-04 | 2020-01-09 | Vaxcyte, Inc. | Ameliorations apportees a des conjugues immunogenes |
PE20211888A1 (es) * | 2018-12-19 | 2021-09-22 | Merck Sharp & Dohme | Composiciones que comprenden conjugados de polisacarido de streptococcus pneumoniae con proteina y sus metodos de uso |
MA55528A (fr) * | 2019-04-02 | 2022-02-09 | Vaxcyte Inc | Synthèse acellulaire optimisée d'antigène b de plasmide d'invasion, compositions associées et procédés d'utilisation |
CN111909256A (zh) | 2019-05-10 | 2020-11-10 | 宁波鲲鹏生物科技有限公司 | 多肽衍生物及其制备方法 |
WO2020247301A1 (fr) * | 2019-06-05 | 2020-12-10 | Merck Sharp & Dohme Corp. | Procédés de traitement de patients avec une composition immunogène qui protège contre le sérotype 29 de s. pneumoniae |
KR20210010412A (ko) * | 2019-07-18 | 2021-01-27 | (주)셀트리온 | 다가 폐렴구균 다당류-단백질 접합체를 포함하는 면역원성 조성물 |
CN112394115A (zh) * | 2019-08-19 | 2021-02-23 | 鲁南制药集团股份有限公司 | 一种聚乙二醇化重组粒细胞刺激因子peg俢饰度的检测方法 |
CN110845587B (zh) * | 2019-10-15 | 2021-06-29 | 康希诺生物股份公司 | 一种定点突变的载体蛋白及其在制备疫苗中的用途 |
AU2021224585A1 (en) | 2020-02-18 | 2022-10-13 | Vaxcyte, Inc. | Group A strep immunogenic compositions with polysaccharide-protein conjugates |
CN111533792B (zh) * | 2020-07-07 | 2020-10-16 | 康希诺生物股份公司 | 一种定点突变的载体蛋白及其在制备疫苗中的用途 |
IL305201A (en) * | 2021-02-17 | 2023-10-01 | Vaxcyte Inc | Methods for the distillation of polysaccharides and their polypeptide conjugates |
WO2023135515A1 (fr) * | 2022-01-13 | 2023-07-20 | Pfizer Inc. | Compositions immunogènes à base d'antigènes saccharidiques capsulaires conjugués et leurs utilisations |
WO2023161817A1 (fr) * | 2022-02-25 | 2023-08-31 | Pfizer Inc. | Procédés d'incorporation de groupes azido dans des polysaccharides capsulaires bactériens |
WO2023194971A2 (fr) * | 2022-04-08 | 2023-10-12 | St. Jude Children's Research Hospital | Compositions immunogènes et procédés de réduction de la transmission d'agents pathogènes |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2510606A1 (fr) | 1981-07-30 | 1983-02-04 | Berri Balzac | Procede d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application a la preparation de vaccins |
JP2921574B2 (ja) | 1988-02-01 | 1999-07-19 | アメリカン・サイアナミド・カンパニー | 接合体ワクチンの担体分子としてのt細胞のエピトープ |
US7709001B2 (en) | 2005-04-08 | 2010-05-04 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
EP1868645B1 (fr) * | 2005-04-08 | 2012-03-07 | Wyeth LLC | Composition conjuguee polysaccharide-proteine pneumococcique polyvalente |
US20070184072A1 (en) | 2005-04-08 | 2007-08-09 | Wyeth | Multivalent pneumococcal polysaccharide-protein conjugate composition |
EP3466982B1 (fr) | 2005-04-08 | 2020-06-17 | Wyeth LLC | Separation de contaminants a partir de polysaccharide de streptococcus pneumoniae par manipulation du ph |
US7955605B2 (en) | 2005-04-08 | 2011-06-07 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
NO345368B1 (no) | 2005-12-22 | 2021-01-04 | Glaxosmithkline Biologicals Sa | Streptococcus pneumoniae immunogen sammensetning for anvendelse ved behandling eller forebygging av sykdommer forårsaket av Streptococcus pneumoniae infeksjon ved serotype 19A-stammer. |
CA2657811C (fr) | 2006-06-29 | 2014-10-21 | The Board Of Trustees Of The Leland Stanford Junior University | Synthese acellulaire de proteines contenant des acides amines non naturels |
RU2460539C2 (ru) | 2006-10-10 | 2012-09-10 | Вайет | СПОСОБ ОЧИСТКИ ПОЛИСАХАРИДОВ Streptococcus pneumoniae 3 ТИПА (ВАРИАНТЫ) |
EP2129693B1 (fr) | 2007-03-23 | 2016-12-07 | Wyeth LLC | Procédé rapide de purification utilisé pour produire des polysaccharides capsulaires de streptococcus pneumoniae |
CA2756533A1 (fr) | 2009-03-24 | 2010-09-30 | Novartis Ag | Combinaisons de proteine liant le facteur h de meningocoque et de conjugues de saccharide de pneumocoque |
GB201003924D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Immunogenic composition |
GB201003922D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Conjugation process |
JP6048845B2 (ja) * | 2011-06-01 | 2016-12-21 | シャモン ユニヴァーシティー | ジフテリア毒素の無毒性突然変異体crm197又はその断片を含む融合タンパク質 |
RU2636350C2 (ru) * | 2011-11-07 | 2017-11-22 | Новартис Аг | МОЛЕКУЛА, СОДЕРЖАЩАЯ SPR0096 и SPR2021 |
EP4074728A1 (fr) | 2012-08-31 | 2022-10-19 | Sutro Biopharma, Inc. | Peptides modifiés comprenant un groupe azido |
GB201300707D0 (en) | 2013-01-15 | 2013-02-27 | Novartis Ag | Compounds and processes |
US9988619B2 (en) | 2013-10-11 | 2018-06-05 | Sutro Biopharma, Inc. | Non-natural amino acid tRNA synthetases for pyridyl tetrazine |
WO2015054658A1 (fr) | 2013-10-11 | 2015-04-16 | Sutro Biopharma, Inc. | Acides aminés modifiés comprenant des groupes fonctionnels de tétrazine, procédés de préparation et procédés d'utilisation associés |
ES2697778T3 (es) * | 2013-10-11 | 2019-01-28 | Sutro Biopharma Inc | ARNt sintetasas de aminoácidos no naturales para para-metilazido-L-fenilalanina |
EP3607966A1 (fr) * | 2014-01-21 | 2020-02-12 | Pfizer Inc | Compositions immunogènes comprenant des antigènes saccharidiques capsulaires conjugués et leurs utilisations |
WO2015110940A2 (fr) | 2014-01-21 | 2015-07-30 | Pfizer Inc. | Polysaccharides capsulaires de streptococcus pneumoniae et conjugués de ceux-ci |
EP3436061A4 (fr) | 2016-03-31 | 2019-12-04 | Liffey Biotech Limited | Compositions de conjugués saccharide-polypeptide polymérisables et leurs procédés d'utilisation |
-
2017
- 2017-12-29 CA CA3048981A patent/CA3048981A1/fr active Pending
- 2017-12-29 KR KR1020197022248A patent/KR20190103256A/ko not_active IP Right Cessation
- 2017-12-29 AU AU2017388891A patent/AU2017388891A1/en active Pending
- 2017-12-29 EP EP17840524.7A patent/EP3562503A2/fr active Pending
- 2017-12-29 MA MA047223A patent/MA47223A/fr unknown
- 2017-12-29 WO PCT/US2017/069129 patent/WO2018126229A2/fr active Application Filing
- 2017-12-29 CN CN201780087608.4A patent/CN110366428B/zh active Active
- 2017-12-29 MX MX2019007910A patent/MX2019007910A/es unknown
- 2017-12-29 BR BR112019013475-1A patent/BR112019013475A2/pt unknown
- 2017-12-29 JP JP2019536194A patent/JP7186166B2/ja active Active
-
2019
- 2019-06-27 IL IL267709A patent/IL267709A/en unknown
- 2019-06-28 MX MX2022014980A patent/MX2022014980A/es unknown
- 2019-07-01 PH PH12019501552A patent/PH12019501552A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN110366428A (zh) | 2019-10-22 |
WO2018126229A2 (fr) | 2018-07-05 |
AU2017388891A1 (en) | 2019-07-04 |
BR112019013475A2 (pt) | 2020-02-27 |
EP3562503A2 (fr) | 2019-11-06 |
JP2020504760A (ja) | 2020-02-13 |
JP2023022188A (ja) | 2023-02-14 |
US20180333484A1 (en) | 2018-11-22 |
WO2018126229A9 (fr) | 2019-07-25 |
IL267709A (en) | 2019-08-29 |
CA3048981A1 (fr) | 2018-07-05 |
MX2022014980A (es) | 2023-01-04 |
JP7186166B2 (ja) | 2022-12-08 |
KR20190103256A (ko) | 2019-09-04 |
PH12019501552A1 (en) | 2020-06-01 |
WO2018126229A3 (fr) | 2018-08-09 |
MX2019007910A (es) | 2019-12-05 |
CN110366428B (zh) | 2024-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA47223A (fr) | Conjugués polypeptide-antigène avec des acides aminés non naturels | |
DK3592393T3 (da) | Frigørbare konjugater | |
DK3433368T3 (da) | Transreplikerende rna | |
MA42134A (fr) | Conjugués peptides/oligonucléotides | |
DK3268047T3 (da) | Amatoxin/antistof-konjugater | |
DK3416974T3 (da) | Proteinoprensning | |
FI20165867A (fi) | Valoherkiste | |
DK3582629T3 (da) | Marinade | |
MA43685A (fr) | Solutions aqueuses d'acides aminés n-acylés | |
DK3544634T3 (da) | MET-antistof-lægemiddelkonjugater | |
MA43873A (fr) | Dspositif d'injection | |
DK3102195T3 (da) | Beta-substituerede beta-aminosyrer og analoger som kemoterapeutiske midler | |
FI20165515A (fi) | Muunneltuja dekstraanikonjugaatteja | |
BR112017023274A2 (pt) | válvula de injeção | |
DK3634384T3 (da) | Levodopa-infusionsopløsning | |
DK3402573T3 (da) | Aminosyreholdig sammensætning | |
GB2559943B (en) | Fencing clip | |
DK3303243T3 (da) | Spejl med forbedret holdbarhed | |
MA45420A (fr) | Traitements combinés avec seribantumab | |
DK3560348T3 (da) | Aminosyredrik med allulose | |
FR3050788B1 (fr) | Robinet de degustation | |
ITUB20153232A1 (it) | Seduta o panchina attrezzata | |
DE112016005030A5 (de) | Liege- und sitzelement | |
DE102016113775B8 (de) | Rückenmassagegerät | |
CL2018001445S1 (es) | Tapabarro |